Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant burden on patients ’ quality of life and impaired sleep quality. The most common CRSwNP endotype is characterized by type-2 inflammation, with enhanced production of interleukin (IL)-4, IL-5 and IL-13. Dupilumab is a monoclonal antibody against IL-4 receptor-alpha, which inhibits both IL-4 and IL-13 signaling, and w as recently approved for treatment of CRSwNP.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Sebastian Ferri, Carlo Montagna, Marta Casini, Luca Malvezzi, Francesca Pirola, Elena Russo, Francesca Racca, Maria Rita Messina, Francesca Puggioni, Emanuele Nappi, Giovanni Costanzo, Lorenzo Del Moro, Giuseppe Mercante, Giuseppe Spriano, Giorgio Walter Tags: Original Article Source Type: research